Cargando…
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
In cell line studies, BCL-2, BAX, as well as novel MEK1 protein levels have strong influence on ovarian cancer response to cisplatin-based chemotherapy. However, such associations have not been demonstrated clinically. We evaluated prognostic/predictive significance of these proteins with regard to...
Autores principales: | Kupryjańczyk, J, Szymańska, T, Mądry, R, Timorek, A, Stelmachów, J, Karpińska, G, Rembiszewska, A, Ziółkowska, I, Kraszewska, E, Dębniak, J, Emerich, J, Ułańska, M, Płużańska, A, Jędryka, M, Goluda, M, Chudecka-Głaz, A, Rzepka-Górska, I, Klimek, M, Urbański, K, Bręborowicz, J, Zieliński, J, Markowska, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377076/ https://www.ncbi.nlm.nih.gov/pubmed/12644821 http://dx.doi.org/10.1038/sj.bjc.6600789 |
Ejemplares similares
-
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004) -
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
por: Kupryjanczyk, Jolanta, et al.
Publicado: (2008) -
Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction
por: Kupryjánczyk, J, et al.
Publicado: (2000) -
Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors
por: Chudecka-Głaz, Anita, et al.
Publicado: (2013) -
Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon
por: Kiedrowski, Miroslaw, et al.
Publicado: (2014)